HEADER MEMBRANE PROTEIN 02-JUL-21 7RAN TITLE 5-HT2AR BOUND TO A NOVEL AGONIST IN COMPLEX WITH A MINI-GQ PROTEIN AND TITLE 2 AN ACTIVE-STATE STABILIZING SINGLE-CHAIN VARIABLE FRAGMENT (SCFV16) TITLE 3 OBTAINED BY CRYO-ELECTRON MICROSCOPY (CRYOEM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5-HYDROXYTRYPTAMINE RECEPTOR 2A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 66-404; COMPND 5 SYNONYM: 5-HT-2,5-HT-2A,SEROTONIN RECEPTOR 2A; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: G PROTEIN SUBUNIT Q (GI2-MINI-GQ CHIMERA); COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(T) SUBUNIT COMPND 13 BETA-1; COMPND 14 CHAIN: C; COMPND 15 SYNONYM: TRANSDUCIN BETA CHAIN 1; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(O) SUBUNIT COMPND 19 GAMMA-2; COMPND 20 CHAIN: D; COMPND 21 SYNONYM: G GAMMA-I; COMPND 22 ENGINEERED: YES; COMPND 23 MOL_ID: 5; COMPND 24 MOLECULE: SINGLE-CHAIN VARIABLE FRAGMENT 16 (SCFV16); COMPND 25 CHAIN: E; COMPND 26 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HTR2A, HTR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 16 MOL_ID: 3; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 GENE: GNB1; SOURCE 21 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 22 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 24 MOL_ID: 4; SOURCE 25 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 26 ORGANISM_COMMON: HUMAN; SOURCE 27 ORGANISM_TAXID: 9606; SOURCE 28 GENE: GNG2; SOURCE 29 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 30 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 31 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 32 MOL_ID: 5; SOURCE 33 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 34 ORGANISM_COMMON: HUMAN; SOURCE 35 ORGANISM_TAXID: 9606; SOURCE 36 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 37 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 38 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS 5-HT2A RECEPTOR, SEROTONIN RECEPTOR, G PROTEIN, GPCR, NOVEL AGONIST, KEYWDS 2 CRYOEM, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR X.BARROS-ALVAREZ,K.KIM,O.PANOVA,B.L.ROTH,G.SKINIOTIS REVDAT 3 02-NOV-22 7RAN 1 JRNL REVDAT 2 12-OCT-22 7RAN 1 JRNL REVDAT 1 06-JUL-22 7RAN 0 JRNL AUTH A.L.KAPLAN,D.N.CONFAIR,K.KIM,X.BARROS-ALVAREZ,R.M.RODRIGUIZ, JRNL AUTH 2 Y.YANG,O.S.KWEON,T.CHE,J.D.MCCORVY,D.N.KAMBER,J.P.PHELAN, JRNL AUTH 3 L.C.MARTINS,V.M.POGORELOV,J.F.DIBERTO,S.T.SLOCUM,X.P.HUANG, JRNL AUTH 4 J.M.KUMAR,M.J.ROBERTSON,O.PANOVA,A.B.SEVEN,A.Q.WETSEL, JRNL AUTH 5 W.C.WETSEL,J.J.IRWIN,G.SKINIOTIS,B.K.SHOICHET,B.L.ROTH, JRNL AUTH 6 J.A.ELLMAN JRNL TITL BESPOKE LIBRARY DOCKING FOR 5-HT 2A RECEPTOR AGONISTS WITH JRNL TITL 2 ANTIDEPRESSANT ACTIVITY. JRNL REF NATURE V. 610 582 2022 JRNL REFN ESSN 1476-4687 JRNL PMID 36171289 JRNL DOI 10.1038/S41586-022-05258-Z REMARK 2 REMARK 2 RESOLUTION. 3.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, SERIALEM, RELION, RELION, REMARK 3 RELION, RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.450 REMARK 3 NUMBER OF PARTICLES : 88393 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7RAN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1000256866. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : 5-HT2AR BOUND TO A REMARK 245 TETRAHYDROPYRIDINE AGONIST (R- REMARK 245 69) IN COMPLEX WITH REMARK 245 HETEROTRIMERIC MINI-GQ PROTEIN REMARK 245 AND SINGLE-CHAIN VARIABLE REMARK 245 FRAGMENT (SCFV16) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 17.40 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6001.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : 57050 REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 66 REMARK 465 SER A 67 REMARK 465 LEU A 68 REMARK 465 LEU A 69 REMARK 465 HIS A 70 REMARK 465 LEU A 71 REMARK 465 GLN A 72 REMARK 465 GLU A 73 REMARK 465 LYS A 74 REMARK 465 ASN A 75 REMARK 465 TRP A 76 REMARK 465 SER A 77 REMARK 465 ALA A 78 REMARK 465 LEU A 267 REMARK 465 CYS A 268 REMARK 465 VAL A 269 REMARK 465 SER A 270 REMARK 465 ASP A 271 REMARK 465 LEU A 272 REMARK 465 GLY A 273 REMARK 465 THR A 274 REMARK 465 ARG A 275 REMARK 465 ALA A 276 REMARK 465 LYS A 277 REMARK 465 LEU A 278 REMARK 465 ALA A 279 REMARK 465 SER A 280 REMARK 465 PHE A 281 REMARK 465 SER A 282 REMARK 465 PHE A 283 REMARK 465 LEU A 284 REMARK 465 PRO A 285 REMARK 465 GLN A 286 REMARK 465 SER A 287 REMARK 465 SER A 288 REMARK 465 LEU A 289 REMARK 465 SER A 290 REMARK 465 SER A 291 REMARK 465 GLU A 292 REMARK 465 LYS A 293 REMARK 465 LEU A 294 REMARK 465 PHE A 295 REMARK 465 GLN A 296 REMARK 465 ARG A 297 REMARK 465 SER A 298 REMARK 465 ILE A 299 REMARK 465 HIS A 300 REMARK 465 ARG A 301 REMARK 465 GLU A 302 REMARK 465 PRO A 303 REMARK 465 GLY A 304 REMARK 465 SER A 305 REMARK 465 TYR A 306 REMARK 465 THR A 307 REMARK 465 GLY A 308 REMARK 465 ARG A 309 REMARK 465 ARG A 310 REMARK 465 THR A 311 REMARK 465 MET A 312 REMARK 465 LYS A 350 REMARK 465 GLU A 351 REMARK 465 SER A 352 REMARK 465 CYS A 353 REMARK 465 GLN A 398 REMARK 465 TYR A 399 REMARK 465 LYS A 400 REMARK 465 GLU A 401 REMARK 465 ASN A 402 REMARK 465 LYS A 403 REMARK 465 LYS A 404 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 SER B 3 REMARK 465 ILE B 55 REMARK 465 LEU B 56 REMARK 465 HIS B 57 REMARK 465 GLY B 58 REMARK 465 GLY B 59 REMARK 465 SER B 60 REMARK 465 GLY B 61 REMARK 465 GLY B 62 REMARK 465 SER B 63 REMARK 465 GLY B 64 REMARK 465 GLY B 65 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 SER D 3 REMARK 465 ASN D 4 REMARK 465 ASN D 5 REMARK 465 THR D 6 REMARK 465 ALA D 7 REMARK 465 SER D 8 REMARK 465 ARG D 62 REMARK 465 GLU D 63 REMARK 465 LYS D 64 REMARK 465 LYS D 65 REMARK 465 PHE D 66 REMARK 465 PHE D 67 REMARK 465 CYS D 68 REMARK 465 ALA D 69 REMARK 465 ILE D 70 REMARK 465 LEU D 71 REMARK 465 MET E -37 REMARK 465 LEU E -36 REMARK 465 LEU E -35 REMARK 465 VAL E -34 REMARK 465 ASN E -33 REMARK 465 GLN E -32 REMARK 465 SER E -31 REMARK 465 HIS E -30 REMARK 465 GLN E -29 REMARK 465 GLY E -28 REMARK 465 PHE E -27 REMARK 465 ASN E -26 REMARK 465 LYS E -25 REMARK 465 GLU E -24 REMARK 465 HIS E -23 REMARK 465 THR E -22 REMARK 465 SER E -21 REMARK 465 LYS E -20 REMARK 465 MET E -19 REMARK 465 VAL E -18 REMARK 465 SER E -17 REMARK 465 ALA E -16 REMARK 465 ILE E -15 REMARK 465 VAL E -14 REMARK 465 LEU E -13 REMARK 465 TYR E -12 REMARK 465 VAL E -11 REMARK 465 LEU E -10 REMARK 465 LEU E -9 REMARK 465 ALA E -8 REMARK 465 ALA E -7 REMARK 465 ALA E -6 REMARK 465 ALA E -5 REMARK 465 HIS E -4 REMARK 465 SER E -3 REMARK 465 ALA E -2 REMARK 465 PHE E -1 REMARK 465 ALA E 0 REMARK 465 ASP E 1 REMARK 465 TRP E 36 REMARK 465 SER E 119A REMARK 465 SER E 119B REMARK 465 GLY E 119C REMARK 465 GLY E 119D REMARK 465 GLY E 119E REMARK 465 GLY E 119F REMARK 465 SER E 119G REMARK 465 GLY E 119H REMARK 465 GLY E 119I REMARK 465 GLY E 119J REMARK 465 GLY E 119K REMARK 465 SER E 119L REMARK 465 GLY E 119M REMARK 465 GLY E 119N REMARK 465 GLY E 119O REMARK 465 GLY E 119P REMARK 465 SER E 119Q REMARK 465 LYS E 236 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 86 CG1 CG2 CD1 REMARK 470 ILE A 93 CG1 CG2 CD1 REMARK 470 MET A 97 CG SD CE REMARK 470 LYS A 103 CG CD CE NZ REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 GLN A 106 CG CD OE1 NE2 REMARK 470 PHE A 125 CG CD1 CD2 CE1 CE2 CZ REMARK 470 MET A 128 CG SD CE REMARK 470 LEU A 136 CG CD1 CD2 REMARK 470 TYR A 139 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 140 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 143 CG CD1 CD2 REMARK 470 LYS A 146 CG CD CE NZ REMARK 470 ARG A 189 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 195 CG CD CE NZ REMARK 470 ILE A 210 CG1 CG2 CD1 REMARK 470 GLN A 216 CG CD OE1 NE2 REMARK 470 ASP A 218 CG OD1 OD2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 LEU A 228 CG CD1 CD2 REMARK 470 ILE A 237 CG1 CG2 CD1 REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 GLU A 264 CG CD OE1 OE2 REMARK 470 MET A 335 CG SD CE REMARK 470 ASN A 354 CG OD1 ND2 REMARK 470 VAL A 357 CG1 CG2 REMARK 470 LYS A 385 CG CD CE NZ REMARK 470 GLN B 52 CG CD OE1 NE2 REMARK 470 PHE B 70 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 78 CG CD CE NZ REMARK 470 ASP B 91 CG OD1 OD2 REMARK 470 ARG B 94 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 111 CG OD1 OD2 REMARK 470 GLU B 120 CG CD OE1 OE2 REMARK 470 LEU B 148 CG CD1 CD2 REMARK 470 LYS B 157 CG CD CE NZ REMARK 470 GLU B 161 CG CD OE1 OE2 REMARK 470 GLU B 174 CG CD OE1 OE2 REMARK 470 GLU B 179 CG CD OE1 OE2 REMARK 470 LYS B 195 CG CD CE NZ REMARK 470 ASP B 206 CG OD1 OD2 REMARK 470 LEU C 4 CG CD1 CD2 REMARK 470 ARG C 8 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 10 CG CD OE1 OE2 REMARK 470 GLU C 12 CG CD OE1 OE2 REMARK 470 ARG C 19 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 35 CG OD1 ND2 REMARK 470 GLN C 44 CG CD OE1 NE2 REMARK 470 ARG C 46 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 197 CG CD NE CZ NH1 NH2 REMARK 470 ASP C 291 CG OD1 OD2 REMARK 470 ARG D 13 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 17 CG CD OE1 OE2 REMARK 470 MET D 21 CG SD CE REMARK 470 ASP D 26 CG OD1 OD2 REMARK 470 LYS D 29 CG CD CE NZ REMARK 470 LYS D 32 CG CD CE NZ REMARK 470 ASP D 36 CG OD1 OD2 REMARK 470 LYS D 46 CG CD CE NZ REMARK 470 GLU E 46 CG CD OE1 OE2 REMARK 470 LYS E 76 CG CD CE NZ REMARK 470 GLU E 89 CG CD OE1 OE2 REMARK 470 GLN E 130 CG CD OE1 NE2 REMARK 470 THR E 132 OG1 CG2 REMARK 470 GLU E 141 CG CD OE1 OE2 REMARK 470 ARG E 206 CG CD NE CZ NH1 NH2 REMARK 470 GLU E 210 CG CD OE1 OE2 REMARK 470 GLU E 234 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER C 331 OD1 ASP C 333 2.09 REMARK 500 OD1 ASN A 110 OH TYR A 387 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 106 30.59 -93.41 REMARK 500 LEU A 147 58.88 -95.79 REMARK 500 THR B 48 33.24 -99.90 REMARK 500 LYS B 78 -6.12 68.70 REMARK 500 THR C 87 48.04 37.49 REMARK 500 GLU C 130 -0.32 57.41 REMARK 500 ASP C 153 -166.20 -128.91 REMARK 500 LEU C 198 143.20 -170.66 REMARK 500 VAL E 48 -63.20 -121.67 REMARK 500 ALA E 92 -169.52 -169.40 REMARK 500 MET E 180 -12.17 73.38 REMARK 500 SER E 181 -36.69 -130.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-24378 RELATED DB: EMDB REMARK 900 5-HT2AR BOUND TO A NOVEL AGONIST IN COMPLEX WITH A MINI-GQ PROTEIN REMARK 900 AND AN ACTIVE-STATE STABILIZING SINGLE-CHAIN VARIABLE FRAGMENT REMARK 900 (SCFV16) OBTAINED BY CRYO-ELECTRON MICROSCOPY (CRYOEM) DBREF 7RAN A 66 404 UNP P28223 5HT2A_HUMAN 66 404 DBREF 7RAN B 1 246 PDB 7RAN 7RAN 1 246 DBREF 7RAN C 1 340 UNP P62873 GBB1_HUMAN 1 340 DBREF 7RAN D 1 71 UNP P59768 GBG2_HUMAN 1 71 DBREF 7RAN E -37 236 PDB 7RAN 7RAN -37 236 SEQRES 1 A 339 LEU SER LEU LEU HIS LEU GLN GLU LYS ASN TRP SER ALA SEQRES 2 A 339 LEU LEU THR ALA VAL VAL ILE ILE LEU THR ILE ALA GLY SEQRES 3 A 339 ASN ILE LEU VAL ILE MET ALA VAL SER LEU GLU LYS LYS SEQRES 4 A 339 LEU GLN ASN ALA THR ASN TYR PHE LEU MET SER LEU ALA SEQRES 5 A 339 ILE ALA ASP MET LEU LEU GLY PHE LEU VAL MET PRO VAL SEQRES 6 A 339 SER MET LEU THR ILE LEU TYR GLY TYR ARG TRP PRO LEU SEQRES 7 A 339 PRO SER LYS LEU CYS ALA VAL TRP ILE TYR LEU ASP VAL SEQRES 8 A 339 LEU PHE SER THR ALA SER ILE MET HIS LEU CYS ALA ILE SEQRES 9 A 339 SER LEU ASP ARG TYR VAL ALA ILE GLN ASN PRO ILE HIS SEQRES 10 A 339 HIS SER ARG PHE ASN SER ARG THR LYS ALA PHE LEU LYS SEQRES 11 A 339 ILE ILE ALA VAL TRP THR ILE SER VAL GLY ILE SER MET SEQRES 12 A 339 PRO ILE PRO VAL PHE GLY LEU GLN ASP ASP SER LYS VAL SEQRES 13 A 339 PHE LYS GLU GLY SER CYS LEU LEU ALA ASP ASP ASN PHE SEQRES 14 A 339 VAL LEU ILE GLY SER PHE VAL SER PHE PHE ILE PRO LEU SEQRES 15 A 339 THR ILE MET VAL ILE THR TYR PHE LEU THR ILE LYS SER SEQRES 16 A 339 LEU GLN LYS GLU ALA THR LEU CYS VAL SER ASP LEU GLY SEQRES 17 A 339 THR ARG ALA LYS LEU ALA SER PHE SER PHE LEU PRO GLN SEQRES 18 A 339 SER SER LEU SER SER GLU LYS LEU PHE GLN ARG SER ILE SEQRES 19 A 339 HIS ARG GLU PRO GLY SER TYR THR GLY ARG ARG THR MET SEQRES 20 A 339 GLN SER ILE SER ASN GLU GLN LYS ALA CYS LYS VAL LEU SEQRES 21 A 339 GLY ILE VAL PHE PHE LEU PHE VAL VAL MET TRP CYS PRO SEQRES 22 A 339 PHE PHE ILE THR ASN ILE MET ALA VAL ILE CYS LYS GLU SEQRES 23 A 339 SER CYS ASN GLU ASP VAL ILE GLY ALA LEU LEU ASN VAL SEQRES 24 A 339 PHE VAL TRP ILE GLY TYR LEU SER SER ALA VAL ASN PRO SEQRES 25 A 339 LEU VAL TYR THR LEU PHE ASN LYS THR TYR ARG SER ALA SEQRES 26 A 339 PHE SER ARG TYR ILE GLN CYS GLN TYR LYS GLU ASN LYS SEQRES 27 A 339 LYS SEQRES 1 B 246 MET GLY SER THR VAL SER ALA GLU ASP LYS ALA ALA ALA SEQRES 2 B 246 GLU ARG SER LYS MET ILE ASP LYS ASN LEU ARG GLU ASP SEQRES 3 B 246 GLY GLU LYS ALA ARG ARG THR LEU ARG LEU LEU LEU LEU SEQRES 4 B 246 GLY ALA ASP ASN SER GLY LYS SER THR ILE VAL LYS GLN SEQRES 5 B 246 MET ARG ILE LEU HIS GLY GLY SER GLY GLY SER GLY GLY SEQRES 6 B 246 THR SER GLY ILE PHE GLU THR LYS PHE GLN VAL ASP LYS SEQRES 7 B 246 VAL ASN PHE HIS MET PHE ASP VAL GLY GLY GLN ARG ASP SEQRES 8 B 246 GLU ARG ARG LYS TRP ILE GLN CYS PHE ASN ASP VAL THR SEQRES 9 B 246 ALA ILE ILE PHE VAL VAL ASP SER SER ASP TYR ASN ARG SEQRES 10 B 246 LEU GLN GLU ALA LEU ASN ASP PHE LYS SER ILE TRP ASN SEQRES 11 B 246 ASN ARG TRP LEU ARG THR ILE SER VAL ILE LEU PHE LEU SEQRES 12 B 246 ASN LYS GLN ASP LEU LEU ALA GLU LYS VAL LEU ALA GLY SEQRES 13 B 246 LYS SER LYS ILE GLU ASP TYR PHE PRO GLU PHE ALA ARG SEQRES 14 B 246 TYR THR THR PRO GLU ASP ALA THR PRO GLU PRO GLY GLU SEQRES 15 B 246 ASP PRO ARG VAL THR ARG ALA LYS TYR PHE ILE ARG LYS SEQRES 16 B 246 GLU PHE VAL ASP ILE SER THR ALA SER GLY ASP GLY ARG SEQRES 17 B 246 HIS ILE CYS TYR PRO HIS PHE THR CYS ALA VAL ASP THR SEQRES 18 B 246 GLU ASN ALA ARG ARG ILE PHE ASN ASP CYS LYS ASP ILE SEQRES 19 B 246 ILE LEU GLN MET ASN LEU ARG GLU TYR ASN LEU VAL SEQRES 1 C 340 MET SER GLU LEU ASP GLN LEU ARG GLN GLU ALA GLU GLN SEQRES 2 C 340 LEU LYS ASN GLN ILE ARG ASP ALA ARG LYS ALA CYS ALA SEQRES 3 C 340 ASP ALA THR LEU SER GLN ILE THR ASN ASN ILE ASP PRO SEQRES 4 C 340 VAL GLY ARG ILE GLN MET ARG THR ARG ARG THR LEU ARG SEQRES 5 C 340 GLY HIS LEU ALA LYS ILE TYR ALA MET HIS TRP GLY THR SEQRES 6 C 340 ASP SER ARG LEU LEU VAL SER ALA SER GLN ASP GLY LYS SEQRES 7 C 340 LEU ILE ILE TRP ASP SER TYR THR THR ASN LYS VAL HIS SEQRES 8 C 340 ALA ILE PRO LEU ARG SER SER TRP VAL MET THR CYS ALA SEQRES 9 C 340 TYR ALA PRO SER GLY ASN TYR VAL ALA CYS GLY GLY LEU SEQRES 10 C 340 ASP ASN ILE CYS SER ILE TYR ASN LEU LYS THR ARG GLU SEQRES 11 C 340 GLY ASN VAL ARG VAL SER ARG GLU LEU ALA GLY HIS THR SEQRES 12 C 340 GLY TYR LEU SER CYS CYS ARG PHE LEU ASP ASP ASN GLN SEQRES 13 C 340 ILE VAL THR SER SER GLY ASP THR THR CYS ALA LEU TRP SEQRES 14 C 340 ASP ILE GLU THR GLY GLN GLN THR THR THR PHE THR GLY SEQRES 15 C 340 HIS THR GLY ASP VAL MET SER LEU SER LEU ALA PRO ASP SEQRES 16 C 340 THR ARG LEU PHE VAL SER GLY ALA CYS ASP ALA SER ALA SEQRES 17 C 340 LYS LEU TRP ASP VAL ARG GLU GLY MET CYS ARG GLN THR SEQRES 18 C 340 PHE THR GLY HIS GLU SER ASP ILE ASN ALA ILE CYS PHE SEQRES 19 C 340 PHE PRO ASN GLY ASN ALA PHE ALA THR GLY SER ASP ASP SEQRES 20 C 340 ALA THR CYS ARG LEU PHE ASP LEU ARG ALA ASP GLN GLU SEQRES 21 C 340 LEU MET THR TYR SER HIS ASP ASN ILE ILE CYS GLY ILE SEQRES 22 C 340 THR SER VAL SER PHE SER LYS SER GLY ARG LEU LEU LEU SEQRES 23 C 340 ALA GLY TYR ASP ASP PHE ASN CYS ASN VAL TRP ASP ALA SEQRES 24 C 340 LEU LYS ALA ASP ARG ALA GLY VAL LEU ALA GLY HIS ASP SEQRES 25 C 340 ASN ARG VAL SER CYS LEU GLY VAL THR ASP ASP GLY MET SEQRES 26 C 340 ALA VAL ALA THR GLY SER TRP ASP SER PHE LEU LYS ILE SEQRES 27 C 340 TRP ASN SEQRES 1 D 71 MET ALA SER ASN ASN THR ALA SER ILE ALA GLN ALA ARG SEQRES 2 D 71 LYS LEU VAL GLU GLN LEU LYS MET GLU ALA ASN ILE ASP SEQRES 3 D 71 ARG ILE LYS VAL SER LYS ALA ALA ALA ASP LEU MET ALA SEQRES 4 D 71 TYR CYS GLU ALA HIS ALA LYS GLU ASP PRO LEU LEU THR SEQRES 5 D 71 PRO VAL PRO ALA SER GLU ASN PRO PHE ARG GLU LYS LYS SEQRES 6 D 71 PHE PHE CYS ALA ILE LEU SEQRES 1 E 286 MET LEU LEU VAL ASN GLN SER HIS GLN GLY PHE ASN LYS SEQRES 2 E 286 GLU HIS THR SER LYS MET VAL SER ALA ILE VAL LEU TYR SEQRES 3 E 286 VAL LEU LEU ALA ALA ALA ALA HIS SER ALA PHE ALA ASP SEQRES 4 E 286 VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN PRO SEQRES 5 E 286 GLY GLY SER ARG LYS LEU SER CYS SER ALA SER GLY PHE SEQRES 6 E 286 ALA PHE SER SER PHE GLY MET HIS TRP VAL ARG GLN ALA SEQRES 7 E 286 PRO GLU LYS GLY LEU GLU TRP VAL ALA TYR ILE SER SER SEQRES 8 E 286 GLY SER GLY THR ILE TYR TYR ALA ASP THR VAL LYS GLY SEQRES 9 E 286 ARG PHE THR ILE SER ARG ASP ASP PRO LYS ASN THR LEU SEQRES 10 E 286 PHE LEU GLN MET THR SER LEU ARG SER GLU ASP THR ALA SEQRES 11 E 286 MET TYR TYR CYS VAL ARG SER ILE TYR TYR TYR GLY SER SEQRES 12 E 286 SER PRO PHE ASP PHE TRP GLY GLN GLY THR THR LEU THR SEQRES 13 E 286 VAL SER SER GLY GLY GLY GLY SER GLY GLY GLY GLY SER SEQRES 14 E 286 GLY GLY GLY GLY SER ASP ILE VAL MET THR GLN ALA THR SEQRES 15 E 286 SER SER VAL PRO VAL THR PRO GLY GLU SER VAL SER ILE SEQRES 16 E 286 SER CYS ARG SER SER LYS SER LEU LEU HIS SER ASN GLY SEQRES 17 E 286 ASN THR TYR LEU TYR TRP PHE LEU GLN ARG PRO GLY GLN SEQRES 18 E 286 SER PRO GLN LEU LEU ILE TYR ARG MET SER ASN LEU ALA SEQRES 19 E 286 SER GLY VAL PRO ASP ARG PHE SER GLY SER GLY SER GLY SEQRES 20 E 286 THR ALA PHE THR LEU THR ILE SER ARG LEU GLU ALA GLU SEQRES 21 E 286 ASP VAL GLY VAL TYR TYR CYS MET GLN HIS LEU GLU TYR SEQRES 22 E 286 PRO LEU THR PHE GLY ALA GLY THR LYS LEU GLU LEU LYS HET 3IQ A 501 16 HETNAM 3IQ (3R)-3-METHYL-5-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL)-1,2,3, HETNAM 2 3IQ 6-TETRAHYDROPYRIDIN-1-IUM FORMUL 6 3IQ C13 H16 N3 1+ HELIX 1 AA1 LEU A 79 GLU A 102 1 24 HELIX 2 AA2 ASN A 107 GLY A 138 1 32 HELIX 3 AA3 CYS A 148 ASN A 179 1 32 HELIX 4 AA4 ASN A 179 PHE A 186 1 8 HELIX 5 AA5 THR A 190 MET A 208 1 19 HELIX 6 AA6 MET A 208 ASP A 217 1 10 HELIX 7 AA7 ASP A 217 PHE A 222 1 6 HELIX 8 AA8 ASP A 231 THR A 266 1 36 HELIX 9 AA9 SER A 314 CYS A 349 1 36 HELIX 10 AB1 GLU A 355 PHE A 383 1 29 HELIX 11 AB2 ASN A 384 CYS A 397 1 14 HELIX 12 AB3 SER B 6 ARG B 31 1 26 HELIX 13 AB4 GLY B 45 ILE B 49 5 5 HELIX 14 AB5 ARG B 117 ASN B 130 1 14 HELIX 15 AB6 LYS B 145 GLY B 156 1 12 HELIX 16 AB7 PHE B 164 ALA B 168 5 5 HELIX 17 AB8 ASP B 183 SER B 204 1 22 HELIX 18 AB9 ASN B 223 TYR B 243 1 21 HELIX 19 AC1 LEU C 4 CYS C 25 1 22 HELIX 20 AC2 THR C 29 THR C 34 1 6 HELIX 21 AC3 THR C 128 ASN C 132 5 5 HELIX 22 AC4 ALA D 10 ASN D 24 1 15 HELIX 23 AC5 LYS D 29 HIS D 44 1 16 SHEET 1 AA1 6 PHE B 70 VAL B 76 0 SHEET 2 AA1 6 VAL B 79 ASP B 85 -1 O MET B 83 N THR B 72 SHEET 3 AA1 6 LEU B 34 GLY B 40 1 N LEU B 34 O HIS B 82 SHEET 4 AA1 6 ALA B 105 ASP B 111 1 O ILE B 107 N LEU B 37 SHEET 5 AA1 6 VAL B 139 ASN B 144 1 O ILE B 140 N ILE B 106 SHEET 6 AA1 6 CYS B 211 PHE B 215 1 O TYR B 212 N LEU B 141 SHEET 1 AA2 4 THR C 47 LEU C 51 0 SHEET 2 AA2 4 LEU C 336 TRP C 339 -1 O ILE C 338 N ARG C 48 SHEET 3 AA2 4 VAL C 327 SER C 331 -1 N VAL C 327 O TRP C 339 SHEET 4 AA2 4 VAL C 315 VAL C 320 -1 N CYS C 317 O GLY C 330 SHEET 1 AA3 4 ILE C 58 TRP C 63 0 SHEET 2 AA3 4 LEU C 69 SER C 74 -1 O ALA C 73 N TYR C 59 SHEET 3 AA3 4 LYS C 78 ASP C 83 -1 O ILE C 80 N SER C 72 SHEET 4 AA3 4 ASN C 88 PRO C 94 -1 O ILE C 93 N LEU C 79 SHEET 1 AA4 4 VAL C 100 TYR C 105 0 SHEET 2 AA4 4 TYR C 111 GLY C 116 -1 O ALA C 113 N ALA C 104 SHEET 3 AA4 4 ILE C 120 ASN C 125 -1 O TYR C 124 N VAL C 112 SHEET 4 AA4 4 ARG C 134 ALA C 140 -1 O SER C 136 N ILE C 123 SHEET 1 AA5 4 LEU C 146 ASP C 153 0 SHEET 2 AA5 4 GLN C 156 SER C 161 -1 O VAL C 158 N ARG C 150 SHEET 3 AA5 4 CYS C 166 ASP C 170 -1 O TRP C 169 N ILE C 157 SHEET 4 AA5 4 GLN C 175 PHE C 180 -1 O THR C 177 N LEU C 168 SHEET 1 AA6 4 VAL C 187 SER C 191 0 SHEET 2 AA6 4 VAL C 200 ALA C 203 -1 O GLY C 202 N SER C 189 SHEET 3 AA6 4 ALA C 208 LEU C 210 -1 O LYS C 209 N SER C 201 SHEET 4 AA6 4 GLN C 220 PHE C 222 -1 O PHE C 222 N ALA C 208 SHEET 1 AA7 4 ILE C 229 PHE C 234 0 SHEET 2 AA7 4 ALA C 240 SER C 245 -1 O ALA C 242 N CYS C 233 SHEET 3 AA7 4 CYS C 250 ASP C 254 -1 O PHE C 253 N PHE C 241 SHEET 4 AA7 4 GLU C 260 TYR C 264 -1 O MET C 262 N LEU C 252 SHEET 1 AA8 4 ILE C 273 PHE C 278 0 SHEET 2 AA8 4 LEU C 284 TYR C 289 -1 O GLY C 288 N THR C 274 SHEET 3 AA8 4 CYS C 294 ASP C 298 -1 O TRP C 297 N LEU C 285 SHEET 4 AA8 4 ARG C 304 LEU C 308 -1 O ALA C 305 N VAL C 296 SHEET 1 AA9 4 GLN E 3 SER E 7 0 SHEET 2 AA9 4 SER E 17 SER E 25 -1 O SER E 23 N VAL E 5 SHEET 3 AA9 4 THR E 78 THR E 84 -1 O MET E 83 N ARG E 18 SHEET 4 AA9 4 PHE E 68 ASP E 73 -1 N ASP E 73 O THR E 78 SHEET 1 AB1 3 GLY E 33 HIS E 35 0 SHEET 2 AB1 3 ALA E 92 SER E 99 -1 O SER E 99 N GLY E 33 SHEET 3 AB1 3 PHE E 110 TRP E 111 -1 O PHE E 110 N ARG E 98 SHEET 1 AB2 4 LEU E 45 GLU E 46 0 SHEET 2 AB2 4 ARG E 38 GLN E 39 -1 N ARG E 38 O GLU E 46 SHEET 3 AB2 4 ALA E 92 SER E 99 -1 O MET E 93 N GLN E 39 SHEET 4 AB2 4 THR E 115 LEU E 117 -1 O LEU E 117 N ALA E 92 SHEET 1 AB3 2 ALA E 49 ILE E 51 0 SHEET 2 AB3 2 ILE E 58 TYR E 60 -1 O TYR E 59 N TYR E 50 SHEET 1 AB4 5 SER E 134 PRO E 136 0 SHEET 2 AB4 5 THR E 231 GLU E 234 1 O LYS E 232 N VAL E 135 SHEET 3 AB4 5 VAL E 214 GLN E 219 -1 N TYR E 215 O THR E 231 SHEET 4 AB4 5 LEU E 162 GLN E 167 -1 N PHE E 165 O TYR E 216 SHEET 5 AB4 5 GLN E 174 TYR E 178 -1 O ILE E 177 N TRP E 164 SHEET 1 AB5 3 VAL E 143 ARG E 148 0 SHEET 2 AB5 3 ALA E 199 ILE E 204 -1 O ILE E 204 N VAL E 143 SHEET 3 AB5 3 PHE E 191 SER E 196 -1 N SER E 194 O THR E 201 SSBOND 1 CYS A 148 CYS A 227 1555 1555 2.04 SSBOND 2 CYS E 22 CYS E 96 1555 1555 2.04 SSBOND 3 CYS E 147 CYS E 217 1555 1555 2.04 CISPEP 1 TYR E 223 PRO E 224 0 1.47 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000